Drastic Reductions Targeted Core Agencies (Image Credits: Media-cldnry.s-nbcnews.com)
Washington – Federal science research has weathered intense pressure from the Trump administration’s budget proposals, with Congress and courts stepping in to maintain vital funding streams.
Drastic Reductions Targeted Core Agencies
The Trump administration outlined sweeping cuts in its fiscal year 2026 budget request, aiming to slash non-defense-related science research and development funding by nearly 36 percent.[1] Specific agencies faced severe blows, including more than a 40 percent reduction at the National Institutes of Health, almost 57 percent at the National Science Foundation, and 24 percent at NASA.[1] Overall federal science spending would have dropped from $198 billion to $154 billion, the largest decline since World War II.[2]
These proposals alarmed researchers and advocates, who warned of stalled innovation and lost jobs. Holden Thorp, editor of Science journals, described the moves as a “betrayal of a partnership that has enabled American innovation and progress.”[1] Early actions in 2025 compounded concerns, with thousands of federal science workers dismissed and grants frozen or terminated.
Courts Deliver Key Victories on Grant Protections
Federal judges issued multiple injunctions against administration policies, most notably blocking a 15 percent cap on indirect research costs that would have saved billions but crippled university labs.[3][1] The U.S. Court of Appeals for the First Circuit upheld this block in January 2026, ruling that the cap violated congressional intent and NIH regulations.[3] Judge Kermit Lipez noted Congress had gone to “great lengths” to protect negotiated rates.
Lawsuits proliferated, with 39 cases tracked by late 2025 involving grant stalling and terminations.[1] Universities like Harvard and Columbia secured settlements or wins to reinstate funding, though appeals lingered. The Association of American Universities and public health groups led many challenges, preserving billions in research dollars.
Congress Rejects Cuts with Bipartisan Bills
Despite Republican control, lawmakers advanced spending packages that largely ignored the president’s requests. The Senate Appropriations Committee proposed keeping NSF funding at $8.75 billion, a mere 1 percent dip from prior levels.[2] Final approvals delivered $48.7 billion to NIH, a $415 million increase, alongside targeted boosts for cancer, Alzheimer’s, and ALS research.[1]
Joanne Padrón Carney of the American Association for the Advancement of Science called the outcome a rejection of “the president’s very dramatic cuts,” noting flat funding felt like a win amid turmoil.[1] Provisions barred future indirect cost caps and mandated NIH grant reports, reinforcing oversight. The House passed the package overwhelmingly, 397-28.
| Agency | Proposed Cut | Actual Change |
|---|---|---|
| NIH | >40% | +$415M |
| NSF | 57% | -3.4% |
| NASA | 24% | -1.6% |
Researchers Face Ongoing Uncertainty
Even with protections, fallout persisted: over 7,800 grants terminated or frozen, affecting 74,000 clinical trial participants, and federal agencies shed 20 percent of staff.[4][1] Universities imposed hiring freezes and saw doctoral applications drop. NIH funded 5-10 percent fewer projects in 2025 through accelerated spending.
- More than 25,000 science personnel departed agencies like EPA, NASA, and FDA.
- New NSF grants fell 25 percent below decade average.
- International student enrollment at U.S. universities declined 17 percent.
- Over 10,000 doctorate-trained experts left government roles.
Scientists like Shelly Sakiyama-Elbert of the University of Washington voiced sleepless nights over lab funding, highlighting distraction from core work.[1]
Key Takeaways
- Congress preserved core funding, proving bipartisan commitment to research.
- Court rulings halted arbitrary caps, safeguarding university operations.
- Structural checks limited executive overreach, averting catastrophe.
The episode underscored the resilience of America’s research ecosystem, where legislative and judicial branches curbed extreme proposals and sustained progress in health, innovation, and discovery. What do you think about these funding battles? Tell us in the comments.
